SHALBY2025-01-012025-03-31SHALBY2025-03-31SHALBY2024-03-31SHALBY2024-04-012025-03-31SHALBY2025-01-012025-03-31in-capmkt:OtherExpenses1MemberSHALBY2025-01-012025-03-31in-capmkt:OtherExpenses2MemberSHALBY2025-01-012025-03-31in-capmkt:OtherExpenses3MemberSHALBY2025-01-012025-03-31in-capmkt:OtherExpenses4MemberSHALBY2024-04-012025-03-31in-capmkt:OtherExpenses1MemberSHALBY2024-04-012025-03-31in-capmkt:OtherExpenses2MemberSHALBY2024-04-012025-03-31in-capmkt:OtherExpenses3MemberSHALBY2024-04-012025-03-31in-capmkt:OtherExpenses4MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2024-04-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2024-04-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2024-04-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2024-04-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-03-31in-capmkt:ReportableSegments1MemberSHALBY2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-03-31in-capmkt:ReportableSegments2MemberSHALBY2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SHALBY2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SHALBY2025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares540797SHALBYNOTLISTEDINE597J01018SHALBY LIMITEDMain BoardEquity2024-04-012025-03-312025-05-292025-05-20INRMillionsQuarterlyFourth quarterMulti segment2025-05-2917:20:002025-05-2918:30:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated2648920000532000002702120000223080000276310000-13491000044807000010669000016229000016279800002709510000-73900000-7390000102720000117700001144900000-1218800000000-1218800003650000-118230000-110150000-11730000-106780000-1145000010748700001000-1.13-1.13-1.13-1.131. The above Consolidated financial results for the quarter and year ended March 31 2025 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on May 29 2025. The Statutory Auditors of the Company have expressed unmodified opinion on the aforesaid results. <BR> <BR> 2.These financial results have been prepared in accordance with Indian Accounting Standards Ind AS as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies Indian Accounting Standards Rules 2015 and relevant amendment thereafter. <BR> <BR> 3.The figures for quarter ended 31st March 2025 and for corresponding quarter ended 31st March 2024 are the balancing figures between the audited figures in respect of the full financial year and the reviewed year to date figures up to the third quarter of the respective financial year. <BR> <BR> 4.Shalby Limited Employees Welfare Trust has acquired 700000 Equity Shares of Shalby Limited in June 2022 pursuant to Employee Stock Option Scheme2021. During the quarter ended March 31 2025 the Company has granted 205265 Stock Options to eligible employees. Till March 31 2025 Company has granted all 700000 Stock Options to eligible employees out of which total 313265 Stock Options were lapsed and 177235 Options were vested and exercised by eligible employees. <BR> <BR> In accordance with the resolution passed by the Nomination and Remuneration Committee the Company has granted 9000 stock options from the pool of 313265 lapsed options and as of March 31 2025 a total of 218500 stock options remain active. <BR> <BR> 5.During the previous year the Company has acquired 87.26 percent stake in shareholding of PK Healthcare Private Limited through preferential allotment of equity shares and secondary acquisition from promoters during January 2024. PK Healthcare Pvt. Ltd. is now a subsidiary of the Company Effective form 25th January 2024. <BR> <BR> 6.During the previous year the Company has acquired 100 percent stake in shareholding of Healers Hospital Private Limited through secondary acquisition from existing shareholders during March 2024. Healers Hospital Pvt. Ltd. is now wholly owned subsidiary of the Company effective from 15th March 2024. <BR> <BR> 7. Shalby Advanced Technologies Inc. USA stepdown subsidiary of the Company has incorporated its subsidiary in India namely Shalby Advanced Technologies India Pvt. Ltd on 11th April 2024 <BR> <BR> 8. The consolidated financial result includes the results of the Company and 14 Subsidiary companies including 4 stepdown subsidiaries. The company together with its subsidiaries is herein referred to as the Group. <BR> <BR> 9.The Company is not a Large Corporate as per the applicability criteria given under the SEBI circular dated 26th November 2018. <BR> <BR> 10. The Code on Social Security 2020 relating to employee benefits during employment and postemployment benefits has received Presidential assent and has been published in the Gazette of India. However the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The Group will assess the impact of the Code when relevant provisions are notified and will record related impact if any in the period the Code becomes effective. <BR> <BR> 11.As per Indian Accounting Standard Ind AS 108 Segment Reporting segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities Manufacturing of Implant. Disclosure for the same is given in the separate note attached herewith in Annexure I. <BR> <BR> 12. Previous period figures have been regrouped recast and rearranged wherever considered necessary to make it comparable. <BR> 2024-04-012025-03-31AuditedConsolidated10869550000275960000111455100009269100001039180000-82002000018458200003871300006576000006551600000105882200005572900000557290000565260000-27170000538090000019200000000019200000-26080000-688000062220000-4302000035840000-427400001074870000108847000000000.180.180.180.18Materials and Consumables398750000Fees to Doctors and Consultants685540000Other Operative expenses206920000Other Expenses336770000Materials and Consumables1686230000Fees to Doctors and Consultants2608070000Other Operative expenses909330000Other Expenses13479700008481710000804200000568590000503660000139240000000002241500002241500006715000039200000010456920000319211000094628000017521300003478500007700000108980000315601000023149000065796100000017036530000107488000088470000009921880000313900009953270000136669000000034700001370160000600400006313500000468470000253002000029004900003966000011445500001184210000187340000427204000024554000035660000004553240000708326000017036530000Healthcare Services2372560000Manufacturing of Implants276360000Healthcare Services9797850000Manufacturing of Implants1071700000264892000010869550000264892000010869550000Healthcare Services158930000Manufacturing of Implants-166320000Healthcare Services960640000Manufacturing of Implants-403350000-7390000557290000-7390000557290000Healthcare Services13530030000Manufacturing of Implants350651000017036540000017036540000Healthcare Services-3321920000Manufacturing of Implants-3761350000-70832700000-7083270000387130000-840090000-3105900000-1316900001586000037590000165800000-821100000-14910000-170300006576000000204000000780000-6000000072250000000-804100000-445900000-458330000989600000001423800000-434200000000000013610000714460000519342000052485100000000000000000000771700000322400000-35637000000750000000001520680000393050000176200000129610000347360000063000047584000076050000076050000271810000347860000Items that will not be reclassified to profit or loss-3610000-3610000Items that will not be reclassified to profit or loss-950000-950000-2030000-1120000-5230000262500003650000-26080000AuditedtrueT R CHADHA & CO. LLPtrue2025-09-30